0 false false false false false false false false false false true false false false false false false No description of principal activity 2022-12-01 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 07960405 2022-12-01 2023-11-30 07960405 2023-11-30 07960405 2022-11-30 07960405 2021-12-01 2022-11-30 07960405 2022-11-30 07960405 2021-11-30 07960405 bus:RegisteredOffice 2022-12-01 2023-11-30 07960405 bus:LeadAgentIfApplicable 2022-12-01 2023-11-30 07960405 bus:Director1 2022-12-01 2023-11-30 07960405 core:ShareCapital 2023-11-30 07960405 core:ShareCapital 2022-11-30 07960405 core:RetainedEarningsAccumulatedLosses 2023-11-30 07960405 core:RetainedEarningsAccumulatedLosses 2022-11-30 07960405 bus:SmallEntities 2022-12-01 2023-11-30 07960405 bus:AuditExemptWithAccountantsReport 2022-12-01 2023-11-30 07960405 bus:SmallCompaniesRegimeForAccounts 2022-12-01 2023-11-30 07960405 bus:PrivateLimitedCompanyLtd 2022-12-01 2023-11-30 07960405 bus:FullAccounts 2022-12-01 2023-11-30
COMPANY REGISTRATION NUMBER: 07960405
Evimed Limited
Unaudited Financial Statements
For the year ended
30 November 2023
Evimed Limited
Financial Statements
Year ended 30 November 2023
Contents
Pages
Officers and professional advisers
1
Director's report
2
Chartered accountants report to the director on the preparation of the unaudited statutory financial statements
3
Statement of financial position
4
Notes to the financial statements
5
Evimed Limited
Officers and Professional Advisers
Director
S L Selwyn
Registered office
Unit G10 Screenworks
22 Highbury Grove
London
N5 2EF
Accountants
Mackenzie Field
Chartered Accountants
Hyde House
The Hyde
Edgware Road
London
NW9 6LA
Evimed Limited
Director's Report
Year ended 30 November 2023
The director presents his report and the unaudited financial statements of the company for the year ended 30 November 2023 .
Director
The director who served the company during the year was as follows:
S L Selwyn
Small company provisions
This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.
This report was approved by the board of directors on 16 August 2024 and signed on behalf of the board by:
S L Selwyn
Director
Registered office:
Unit G10 Screenworks
22 Highbury Grove
London
N5 2EF
Evimed Limited
Chartered Accountants Report to the Director on the Preparation of the Unaudited Statutory Financial Statements of Evimed Limited
Year ended 30 November 2023
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Evimed Limited for the year ended 30 November 2023, which comprise the statement of financial position and the related notes from the company's accounting records and from information and explanations you have given us. As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at www.icaew.com/en/membership/regulations-standards-and-guidance. This report is made solely to the director of Evimed Limited. Our work has been undertaken solely to prepare for your approval the financial statements of Evimed Limited and state those matters that we have agreed to state to you in this report in accordance with ICAEW Technical Release 07/16 AAF as detailed at www.icaew.com/compilation. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Evimed Limited and its director for our work or for this report.
It is your duty to ensure that Evimed Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Evimed Limited. You consider that Evimed Limited is exempt from the statutory audit requirement for the year. We have not been instructed to carry out an audit or a review of the financial statements of Evimed Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.
Mackenzie Field Chartered Accountants
Hyde House The Hyde Edgware Road London NW9 6LA
16 August 2024
Evimed Limited
Statement of Financial Position
30 November 2023
2023
2022
Note
£
£
£
Capital and reserves
Called up share capital
100
100
Profit and loss account
( 100)
( 100)
----
----
Shareholder funds
----
----
These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
For the year ending 30 November 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 16 August 2024 , and are signed on behalf of the board by:
S L Selwyn
Director
Company registration number: 07960405
Evimed Limited
Notes to the Financial Statements
Year ended 30 November 2023
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Unit G10 Screenworks, 22 Highbury Grove, London, N5 2EF.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.